|
× |
 |
Three-Month Follow-up Study of Mental Health Outcomes After a National COVID-19 Lockdown: Comparing Patients With Mood or Anxiety Disorders Living in an Area With a Higher Versus Lower Infection Incidence PDF |
$40.00 |
|
$40.00 |
|
× |
|
Metabolic Syndrome and the Risk of Coronary Heart Disease in 367 Patients Treated With Second-Generation Antipsychotic Drugs. PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on Prescribing Practices: An Analysis of Data From a Large Midwestern State PDF |
$40.00 |
|
$40.00 |
|
× |
|
Self-Reported Reasons for Not Receiving Mental Health Treatment in Adults With Serious Suicidal Thoughts PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Comparison of Rates of Residual Insomnia Symptoms Following Pharmacotherapy or Cognitive-Behavioral Therapy for Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
The EPPIC Follow-Up Study of First-Episode Psychosis: Longer-Term Clinical and Functional Outcome 7 Years After Index Admission PDF |
$40.00 |
|
$40.00 |
|
× |
|
Multiple Strokes in a Patient With Systemic Lupus Erythematosus in the Absence of Common Underlying Syndromes PDF |
$40.00 |
|
$40.00 |
|
× |
|
Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Burden of Subthreshold Posttraumatic Stress Disorder in World Trade Center Responders in the Second Decade After 9/11 PDF |
$40.00 |
|
$40.00 |
|
× |
|
Personality Modulates the Efficacy of Treatment in Patients With Major Depressive Disorder PDF |
$40.00 |
|
$40.00 |
|
|
